Vaeksthormonbehandling af korte børn født small for gestational age

Translated title of the contribution: Growth hormone treatment of short children born small for gestational age

Henrik B Thybo Christesen, Rikke Bodin Beck Jensen, Niels H Birkebaek, Niels Thomas Hertel, Katharina M Main, Henrik B Mortensen, Rune W Naeraa, Anders Juul

    2 Citations (Scopus)

    Abstract

    Short children born small for gestational age (SGA) are defined as having a birth weight below -2 SD for gestational age and a reduced height at four years of age (height <-2.5 SD). Growth hormone (GH) treatment significantly improves final height (mean height gain 12 centimetres) in such children. Consequently, GH therapy has been an approved indication in Europe since 2003 for SGA children who remain short at four years of age. The Danish consensus guidelines for diagnosis, treatment and control of short SGA children are described in this review.
    Translated title of the contributionGrowth hormone treatment of short children born small for gestational age
    Original languageDanish
    JournalUgeskrift for Laeger
    Volume168
    Issue number9
    Pages (from-to)889-95
    Number of pages7
    ISSN0041-5782
    Publication statusPublished - 2006

    Fingerprint

    Dive into the research topics of 'Growth hormone treatment of short children born small for gestational age'. Together they form a unique fingerprint.

    Cite this